Laura K. Raisanen - Publications

Response to the letter to the editor: "pediatric bowel-wall thickness cutoffs: calibration before implementation".

Journal: Inflammatory bowel diseases

Published: June 05, 2026

Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forward.

Journal: Expert review of gastroenterology & hepatology

Published: February 20, 2026

Proximally dominant inflammation at colonoscopy predicts pan-colonic histological remission following oral vancomycin therapy in pediatric ulcerative colitis.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 19, 2026

Bowel Wall Thickness Cutoff Value for Assessing Inflammatory Bowel Disease Activity Using Intestinal Ultrasonography in Children.

Journal: Inflammatory bowel diseases

Published: June 12, 2025

Oral vancomycin solution is superior to capsule in inducing clinical biomarker and endoscopic remission in children with atypical ulcerative colitis.

Journal: British journal of clinical pharmacology

Published: April 10, 2025

Perinatal risk factors and disordered eating in children and adolescents.

Journal: Eating and weight disorders : EWD

Published: November 28, 2024

Outcomes of oral vancomycin therapy in children with atypical ulcerative colitis with or without confirmed primary sclerosing cholangitis: a real-world observational study.

Journal: BMJ open gastroenterology

Published: September 20, 2024

Parental depression and emotional feeding practices are associated with a tendency towards overeating in preadolescents.

Journal: Frontiers in nutrition

Published: September 17, 2024

Liver enzyme profiles after initiating biological treatment in children with inflammatory bowel diseases.

Journal: Journal of pediatric gastroenterology and nutrition

Published: March 27, 2024

Pre-Diagnostic Saliva Microbiota of School-Aged Children Who Developed Type 1 Diabetes or Inflammatory Bowel Diseases.

Journal: International journal of molecular sciences

Published: February 09, 2023

Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases.

Journal: Frontiers in pediatrics

Published: February 02, 2023

Antibiotic exposures and the development of pediatric autoimmune diseases: a register-based case-control study.

Journal: Pediatric research

Published: March 24, 2022